News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,150 Results
Type
Article (41644)
Company Profile (265)
Press Release (686227)
Multimedia
Podcasts (85)
Webinars (20)
Section
Business (205058)
Career Advice (2037)
Deals (35620)
Drug Delivery (121)
Drug Development (81555)
Employer Resources (173)
FDA (16510)
Job Trends (14985)
News (347215)
Policy (32877)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2602)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49679)
ALS (194)
Alzheimer's disease (1745)
Antibody-drug conjugate (ADC) (366)
Approvals (16831)
Artificial intelligence (594)
Autoimmune disease (223)
Automation (50)
Bankruptcy (362)
Best Places to Work (11652)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (175)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (685)
Cancer (5310)
Cardiovascular disease (442)
Career advice (1725)
Career pathing (39)
CAR-T (300)
CDC (54)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (41)
Clinical research (70304)
Collaboration (1888)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2728)
CRISPR (98)
C-suite (973)
Cystic fibrosis (148)
Data (7045)
Decentralized trials (3)
Denatured (26)
Depression (152)
Dermatology (57)
Diabetes (549)
Diagnostics (6834)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (292)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (91133)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (118512)
Executive appointments (1031)
FDA (19935)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1611)
Gene editing (210)
Generative AI (51)
Gene therapy (654)
GLP-1 (1017)
Government (4707)
Grass and pollen (6)
Guidances (397)
Healthcare (18955)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (80)
Indications (157)
Infectious disease (3041)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (316)
IPO (16678)
IRA (50)
Job creations (3650)
Job search strategy (1436)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (554)
Leadership (34)
Legal (7970)
Liver cancer (98)
Longevity (28)
Lung cancer (712)
Lymphoma (407)
Machine learning (52)
Management (59)
Manufacturing (919)
MASH (176)
Medical device (13889)
Medtech (13966)
Mergers & acquisitions (20105)
Metabolic disorders (1408)
mRNA (174)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (383)
Neuropsychiatric disorders (97)
Neuroscience (3135)
Neurotech (1)
NextGen: Class of 2026 (6536)
Non-profit (4530)
Now hiring (73)
Obesity (663)
Opinion (274)
Ovarian cancer (185)
Pain (230)
Pancreatic cancer (253)
Parkinson's disease (336)
Partnered (33)
Patents (553)
Patient recruitment (590)
Peanut (60)
People (59325)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21906)
Phase 2 (30958)
Phase 3 (23052)
Pipeline (7099)
Policy (302)
Postmarket research (2568)
Preclinical (9290)
Press Release (64)
Prostate cancer (275)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (989)
Real estate (5975)
Recruiting (70)
Regulatory (25071)
Reports (54)
Research institute (2411)
Resumes & cover letters (356)
Rett syndrome (32)
RNA editing (17)
RSV (86)
Schizophrenia (163)
Series A (267)
Series B (200)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3634)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (57)
Vaccines (1060)
Venture capital (98)
Weight loss (421)
Women's health (109)
Worklife (19)
Date
Today (55)
Last 7 days (637)
Last 30 days (2673)
Last 365 days (29976)
2026 (7992)
2025 (30226)
2024 (35269)
2023 (40126)
2022 (51268)
2021 (55786)
2020 (54160)
2019 (46675)
2018 (35109)
2017 (32197)
2016 (31558)
2015 (37682)
2014 (31400)
2013 (26475)
2012 (28688)
2011 (29395)
2010 (27432)
Location
Africa (742)
Alabama (90)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (39614)
Australia (6469)
California (12249)
Canada (3520)
China (1224)
Colorado (522)
Connecticut (520)
Delaware (366)
Europe (85761)
Florida (1848)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (955)
India (80)
Indiana (558)
Iowa (22)
Japan (485)
Kansas (129)
Kentucky (44)
Louisiana (39)
Maine (73)
Maryland (1483)
Massachusetts (8758)
Michigan (346)
Minnesota (674)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3268)
New Mexico (28)
New York (3233)
North Carolina (1553)
North Dakota (8)
Northern California (6056)
Ohio (365)
Oklahoma (22)
Oregon (41)
Pennsylvania (2482)
Puerto Rico (26)
Rhode Island (50)
South America (1118)
South Carolina (76)
South Dakota (1)
Southern California (4812)
Tennessee (199)
Texas (1924)
United States (43400)
Utah (368)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (980)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
728,150 Results for "revision optics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myllia Biotechnology and Element Biosciences Demonstrate Successful Multimodal Optical Pooled Screening for Drug Discovery
Collaboration validates integrated RNA, protein, and morphology workflows and expands access to next generation optical pooled screening on the AVITI24™
March 16, 2026
·
1 min read
Press Releases
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
March 25, 2026
·
9 min read
Press Releases
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
March 31, 2026
·
9 min read
Press Releases
GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study
March 9, 2026
·
3 min read
Press Releases
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
February 10, 2026
·
5 min read
Press Releases
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
January 29, 2026
·
3 min read
Press Releases
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
February 9, 2026
·
10 min read
Press Releases
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies
February 24, 2026
·
11 min read
Press Releases
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
January 6, 2026
·
13 min read
Press Releases
OPTIC and Mechanica Partners Expand Strategic Collaboration to Power AI-Driven Venture Creation Across Multiple Programs
Collaboration highlights Mechanica Partners’ innovative use of Optic’s BIOPTIC platform to bridge scientific discovery and strategic business insights for accelerated biotech portfolio growth
June 6, 2025
·
1 min read
1 of 72,815
Next
